跳至主要内容
临床试验/EUCTR2018-000564-28-ES
EUCTR2018-000564-28-ES进行中(未招募)1 期

Genetic characterization of drug-induced Long QT Syndrome

Institut de Recerca H. de la Santa Creu i Sant Pau - IIB Sant Pau0 个研究点目标入组 120 人开始时间: 2018年3月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients older than 18 years with a confirmed diagnosis of drug-induceded long QT syndrome who want to participate in the study and sign the informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 120
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Patients under 18 years old
  • -Patients of non-Caucasian ethnicity
  • -Patients with a family history of congenital long QT syndrome
  • -Patients with complete left bundle branch block, stimulated rhythms or non-sinus rhythms not related to SQTL
  • -Patients with electrolyte abnormalities
  • -Patients who do not sign informed consent

研究者

发起方
Institut de Recerca H. de la Santa Creu i Sant Pau - IIB Sant Pau

相似试验

Genetic characteristics of the Long QT Syndrome that... | 临床试验